Sonoke S - Search Results

1

In vitro and in vivo activities of NS-718, a new lipid nanosphere incorporating amphotericin B, against Aspergillus fumigatus.

Otsubo T, Maesaki S, Hossain MA, Yamamoto Y, Tomono K, Tashiro T, Seki J, Tomii Y, Sonoke S, Kohno S. Otsubo T, et al. Among authors: sonoke s. Antimicrob Agents Chemother. 1999 Mar;43(3):471-5. doi: 10.1128/AAC.43.3.471. Antimicrob Agents Chemother. 1999. PMID: 10049253 Free PMC article.

2

Evaluation of the efficacy and toxicity of amphotericin B incorporated in lipid nano-sphere (LNS).

Fukui H, Koike T, Saheki A, Sonoke S, Tomii Y, Seki J. Fukui H, et al. Among authors: sonoke s. Int J Pharm. 2003 Sep 16;263(1-2):51-60. doi: 10.1016/s0378-5173(03)00342-9. Int J Pharm. 2003. PMID: 12954180

3

Comparison of LNS-AmB, a novel low-dose formulation of amphotericin B with lipid nano-sphere (LNS), with commercial lipid-based formulations.

Fukui H, Koike T, Nakagawa T, Saheki A, Sonoke S, Tomii Y, Seki J. Fukui H, et al. Among authors: sonoke s. Int J Pharm. 2003 Nov 28;267(1-2):101-12. doi: 10.1016/j.ijpharm.2003.08.002. Int J Pharm. 2003. PMID: 14602388

4

A novel delivery system for amphotericin B with lipid nano-sphere (LNS).

Fukui H, Koike T, Saheki A, Sonoke S, Seki J. Fukui H, et al. Among authors: sonoke s. Int J Pharm. 2003 Oct 20;265(1-2):37-45. doi: 10.1016/s0378-5173(03)00404-6. Int J Pharm. 2003. PMID: 14522116

5

A nanometer lipid emulsion, lipid nano-sphere (LNS), as a parenteral drug carrier for passive drug targeting.

Seki J, Sonoke S, Saheki A, Fukui H, Sasaki H, Mayumi T. Seki J, et al. Among authors: sonoke s. Int J Pharm. 2004 Apr 1;273(1-2):75-83. doi: 10.1016/j.ijpharm.2003.12.022. Int J Pharm. 2004. PMID: 15010132

6

Lipid transfer protein transports compounds from lipid nanoparticles to plasma lipoproteins.

Seki J, Sonoke S, Saheki A, Koike T, Fukui H, Doi M, Mayumi T. Seki J, et al. Among authors: sonoke s. Int J Pharm. 2004 May 4;275(1-2):239-48. doi: 10.1016/j.ijpharm.2004.02.008. Int J Pharm. 2004. PMID: 15081154

7

Galactose-modified cationic liposomes as a liver-targeting delivery system for small interfering RNA.

Sonoke S, Ueda T, Fujiwara K, Kuwabara K, Yano J. Sonoke S, et al. Biol Pharm Bull. 2011;34(8):1338-42. doi: 10.1248/bpb.34.1338. Biol Pharm Bull. 2011. PMID: 21804229 Free article.

8

Tumor regression in mice by delivery of Bcl-2 small interfering RNA with pegylated cationic liposomes.

Sonoke S, Ueda T, Fujiwara K, Sato Y, Takagaki K, Hirabayashi K, Ohgi T, Yano J. Sonoke S, et al. Cancer Res. 2008 Nov 1;68(21):8843-51. doi: 10.1158/0008-5472.CAN-08-0127. Cancer Res. 2008. PMID: 18974128

9

Liver target delivery of small interfering RNA to the HCV gene by lactosylated cationic liposome.

Watanabe T, Umehara T, Yasui F, Nakagawa S, Yano J, Ohgi T, Sonoke S, Satoh K, Inoue K, Yoshiba M, Kohara M. Watanabe T, et al. Among authors: sonoke s. J Hepatol. 2007 Dec;47(6):744-50. doi: 10.1016/j.jhep.2007.06.015. Epub 2007 Jul 26. J Hepatol. 2007. PMID: 17822798

10

Therapeutic effects of microRNA-582-5p and -3p on the inhibition of bladder cancer progression.

Uchino K, Takeshita F, Takahashi RU, Kosaka N, Fujiwara K, Naruoka H, Sonoke S, Yano J, Sasaki H, Nozawa S, Yoshiike M, Kitajima K, Chikaraishi T, Ochiya T. Uchino K, et al. Among authors: sonoke s. Mol Ther. 2013 Mar;21(3):610-9. doi: 10.1038/mt.2012.269. Epub 2013 Jan 8. Mol Ther. 2013. PMID: 23295946 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13 results

Search Page

Filters